London: GlaxoSmithKline PLC’s cervical cancer vaccine ‘Cervarix’ has received nod for sale across the European Union.

The vaccine has been sanctioned to avert pre-cancerous wounds and cervical cancer caused by human papillomavirus types 16 and 18 that held responsible for over 70 per cent of all cervical cancer cases.

The world’s second-biggest drug manufacturer said that the indication for Cervarix is based on statistics developed by clinical studies in girls and young women between 10 and 25.

Islamabad, Sep 25: The United States and the European Union are concerned over the recent arrests and detention of leaders of the opposition parties ahead of the presidential election on October 6.

A US embassy statement stated that reports of the detention of the leadership of several major Pakistani political parties are "extremely disturbing and confusing" for the "friends of Pakistan".

BASEL: According to the world’s biggest maker of cancer drugs, Roche Holding AG